ARTICLE | Company News
Aquarius Biotechnologies, Matinas BioPharma deal
February 16, 2015 8:00 AM UTC
Aquarius’ lead products are CAmB ( MAT2203), a lipid-crystal nano-particle formulation of amphotericin B in development to treat oral fungal infection; and C-Amikacin ( MAT2501), a preclinical lipid-...